USFDA accepts dupilumab for priority review in adults with prurigo nodularis
Dupixent would be the first and only medicine specifically indicated to treat prurigo nodularis in the U.S., if approved
Dupixent would be the first and only medicine specifically indicated to treat prurigo nodularis in the U.S., if approved
Low-dose atropine has emerged as an effective approach to slow the progression of myopia in children
PAYBACK loyalty will be live in 4500 Apollo Pharmacy outlets across India
This expansion announcement came right after raising series B funding of $27 Mn in a round led by Fundamentum Partnership, earlier this month.
Evrysdi has proven efficacy in babies, children and adults with more than 5,000 patients treated to date
Avillion announces expansion of partnership with AstraZeneca on PT027 and will fund and execute a new Phase 3b study
This agreement is in addition to the $92 million filling line expansion announced in November 2021
The product will be launched by NATCO's commercial partner Viatris.
New logo reflects Thyrocare’s transformation since 1996 to its current leading position at the cutting edge of Diagnostic services
Glenmark Pharmaceuticals announced its financial results for the fourth quarter ended March 31, 2022
Subscribe To Our Newsletter & Stay Updated